603222 济民健康
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-3.628-3.907-3.9892.34014.028
总资产报酬率 ROA (%)-2.132-2.440-2.5211.3416.255
投入资产回报率 ROIC (%)-2.404-2.806-2.8991.5737.825

边际利润分析
销售毛利率 (%)36.86737.31542.43146.28448.048
营业利润率 (%)-15.945-8.196-4.9005.49115.253
息税前利润/营业总收入 (%)-12.871-6.274-3.3807.73819.414
净利润/营业总收入 (%)-13.568-7.235-5.5003.12012.568

收益指标分析
经营活动净收益/利润总额(%)54.28494.853-53.970155.293101.143
价值变动净收益/利润总额(%)0.012-2.100-8.39721.83220.772
营业外收支净额/利润总额(%)-1.3964.32610.840-7.0563.972

偿债能力分析
流动比率 (X)1.0611.4701.5711.7921.122
速动比率 (X)0.8371.1121.2871.5890.947
资产负债率 (%)40.09935.04933.07034.62143.318
带息债务/全部投入资本 (%)32.83625.56521.94326.95935.268
股东权益/带息债务 (%)191.891272.662337.061265.315176.130
股东权益/负债合计 (%)140.474174.993192.170181.662117.891
利息保障倍数 (X)-4.509-2.737-1.5972.9665.500

营运能力分析
应收账款周转天数 (天)66.32168.84163.18667.73960.525
存货周转天数 (天)125.848113.82687.90499.02578.659